Articles

Poll

Podcasts

Slideshows

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

A patient and dermatologists discuss flare-ups and episodic nature of generalized pustular psoriasis (GPP).

Flare-Ups and Episodic Nature of Generalized Pustular Psoriasis (GPP)

Dermatologists Drs Tina Bhutani and Scott Boswell discuss how patients with generalized pustular psoriasis (GPP) typically present in the hospital.

Presentation of Generalized Pustular Psoriasis (GPP) in the Hospital

TJ Chao and Kristine Kucera, PA’s go into dept of the recent developments in the systemic oral space of plaque psoriasis. 

The Oral Systemic Space of Plaque Psoriasis

Physician assistants TJ Chao and Kristine Kucera discuss how the understanding of plaque psoriasis has changed over time and is now considered a systemic disease. 

Plaque Psoriasis as a Systemic Disease

Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai share advice for improving psoriasis care for patients with skin of color.

Advice for Dermatologists in Treating Psoriasis in Patients With Skin of Color

Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai share how they utilize biologics data from skin of color cohorts in their practice.

Data With Biologics in Patients With Skin of Color

Drs Stein Gold and Desai share their thoughts on the early use of psoriasis systemic treatments in patients with skin of color.

Early Use of Systemic Treatments in Patients With Skin of Color

This meta-analysis demonstrates the possibilities for probiotic supplementation, though additional multi-center clinical studies with larger samples may be needed.


Probiotic Supplementation May Serve as Psoriasis Treatment Option, Study Finds

This post-hoc analysis of clinical and real-world settings looks at both both biologic-naïve and bio-experienced individuals.


Ixekizumab for Psoriasis Led to More Acceptable Responses at Week 12 Versus Other Biologics

The application for generic roflumilast cream, 0.3%, for plaque psoriasis may end up entitling Padagis to 180 days of market exclusivity.



Padagis Israel Pharmaceuticals Submits First-to-File ANDA for Generic Version of Roflumilast

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.